Semanteon Capital Management »

BioCryst Pharmaceuticals shares owned by Semanteon Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Semanteon Capital Management from 13F filings

Historical chart of Semanteon Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Semanteon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Semanteon Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $331k 44k 7.59
2025-03-31 $1.4M 190k 7.50
2024-12-31 $1.5M 198k 7.52
2024-09-30 $1.1M 150k 7.60

More positions owned by Semanteon Capital Management

Bloom Energy Corp Com Cl A (BE)
Helen Of Troy (HELE)
Vishay Intertechnology (VSH)
Confluent Class A Com (CFLT)
Apollo Global Mgmt (APO)
V.F. Corporation (VFC)
Impinj (PI)
Pure Storage Cl A (PSTG)
OSI Systems (OSIS)
Apa Corporation (APA)
Western Digital (WDC)
Hecla Mining Company (HL)
CTS Corporation (CTS)
Nov (NOV)
Robert Half International (RHI)

View all positions for Semanteon Capital Management

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals